Risk of cancer among HIV-infected individuals compared to the background population: Impact of smoking and HIV

AIDS

Volumn 28, Issue 10, 2014, Pages 1499-1508

  Helleberg, Marie ^a   Gerstoft, Jan ^a   Afzal, Shoaib ^b   Kronborg, Gitte ^c   Larsen, Carsten S ^d   Pedersen, Court ^e   Bojesen, Stig E ^b,f   Nordestgaard, Børge G ^b,f   Obel, Niels ^a  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

HIV; Immune deficiency; Non AIDS cancer; Smoking; Tobacco; Virological cancer

Indexed keywords

ADULT; ANUS CANCER; ARTICLE; ATTRIBUTABLE RISK; BLADDER CANCER; BONE CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER OF UNKNOWN PRIMARY SITE; CANCER RISK; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM TUMOR; COLON CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; FEMALE GENITAL TRACT CANCER; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE DEFICIENCY; KAPOSI SARCOMA; KIDNEY CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PENIS CANCER; POPULATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; RISK ASSESSMENT; SMOKING; SOFT TISSUE CANCER; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER; VIRUS INFECTION; VULVA CANCER; COHORT ANALYSIS; COMPLICATION; DENMARK; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DENMARK; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 84902255364     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000283     Document Type: Article

References (35)

1. Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43:27-34.
2. Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, Obel N. Causes of death among Danish HIV patients compared with population controls in the period 1995-2008. Infection 2012; 40:627-634.
3. Simard EP, Pfeiffer RM, Engels EA. Mortality due to cancer among people with AIDS: a novel approach using registrylinkage data and population attributable risk methods. AIDS 2012; 26:1311-1318.
4. Armah KA, McGinnis K, Baker J, Gibert C, Butt F AA, Bryant KJ, et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis 2012; 55:126-136.
5. Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis 2013; 56:727-734.
6. Galvan FH, Bing EG, Fleishman JA, London AS, Caetano R, Burnam MA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol 2002; 63:179-186.
7. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013; 382:1525-1533.
8. Cutrell J, Bedimo R. Non-AIDS-defining Cancers Among HIV-Infected Patients. Curr HIV /AIDS Rep 2013; 10:207-216.
9. Shcherba M, Shuter J, Haigentz M Jr. Current questions in HIV-associated lung cancer. Curr Opin Oncol 2013; 25:511-517.
10. Helleberg M, Haggblom A, Sonnerborg A, Obel N. HIV care in the Swedish-Danish HIV Cohort 1995-2010, closing the gaps. PLoS One 2013; 8:e72257.
11. CPR-kontoret. Det Centrale Personregister. www. cpr.dk [Accessed 4 July 2013]
12. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011; 39:42-45.
13. Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sorensen HT. Cohort profile: the Danish HIV cohort study. Int J Epidemiol 2009; 38:1202-1206.
14. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008; 359:1897-1908.
15. Langsted A, Nordestgaard BG. Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study. Clin Chem 2011; 57:482-489.
16. Nordestgaard BG, Palmer TM, Benn M, Zacho J, Tybjaerg- Hansen A, Davey Smith G, et al. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med 2012; 9:e1001212.
17. Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Obel N, Gerstoft J. No change in viral set point or CD4 cell decline among antiretroviral treatment-naive, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995- 2010. HIV Med 2013; 14:362-369.
18. Danaei G, Vander HS, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005; 366:1784-1793.
19. Browning KK, Wewers ME, Ferketich AK, Diaz P. Tobacco use and cessation in HIV-infected individuals. Clin Chest Med 2013; 34:181-190.
20. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92:709-720.
21. Sinha P, Logan HL, Mendenhall WM. Human papillomavirus, smoking, and head and neck cancer. Am J Otolaryngol 2012; 33:130-136.
22. Guiguet M, Boue F, Cadranel J, Lang JM, Rosenthal E, Costagliola D. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009; 10:1152-1159.
23. Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010; 103:416-422.
24. Albini L, Calabresi A, Gotti D, Ferraresi A, Festa A, Donati F, et al. Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era. AIDS Res Hum Retroviruses 2013; 29:1097-1104.
25. Calabresi A, Ferraresi A, Festa A, Scarcella C, Donato F, Vassallo F, et al. Incidence of AIDS-defining cancers and virus-related and nonvirus-related non-AIDS-defining cancers among HIVinfected patients compared with the general population in a large health district of northern Italy, 1999-2009. HIV Med 2013; 14:481-490.
26. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285:1736-1745.
27. Dubrow R, Silverberg MJ, Park LS, Crothers K, Justice AC. HIV infection, aging, and immune function: implications for cancer risk and prevention. Curr Opin Oncol 2012; 24:506-516.
28. MacDonald DC, Nelson M, Bower M, Powles T. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. World J Gastroenterol 2008; 14:1657-1663.
29. Piketty C, Selinger-Leneman H, Bouvier AM, Belot A, Mary- Krause M, Duvivier C, et al. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV. J Clin Oncol 2012; 30:4360-4366.
30. Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 2011; 20:2551-2559.
31. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011; 103:753-762.
32. Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009; 27:884-890.
33. Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Olshan A, et al. Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis 2013; 57:756-764.
34. Robinson WT, Brown MC, Moody-Thomas S. Smoking and experiences with tobacco cessation among men who have sex with men: New Orleans, 2011. AIDS Behav 2014; 18:324-332.
35. Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Obel N, Gerstoft J. CD4 decline is associated with increased risk of cardiovascular disease, cancer, and death in virally suppressed patients with HIV. Clin Infect Dis 2013; 57:314-321.